CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER
Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples.The invention also provides kits comprising means for detecting said proteins...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
24.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples.The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.
La présente invention concerne une méthode de diagnostic et de pronostic du cancer de l'endomètre dans des échantillons isolés faciles d'accès par détection du niveau d'expression d'une ou de plusieurs protéines. En particulier, provenant d'échantillons de fluide utérin. L'invention concerne également des kits comprenant des moyens pour détecter lesdites protéines pour une utilisation dans le diagnostic et le pronostic de la maladie. |
---|---|
Bibliography: | Application Number: CA20183070041 |